Literature DB >> 28653572

Regulatory T cells, as a target in anticancer immunotherapy.

Tomohiro Enokida1, Hiroyoshi Nishikawa1,2.   

Abstract

Keywords:  cancer; chemokines; immune check point; immunotherapy; microenvironment; regulatory T cell

Mesh：

Substances：

Year:  2017        PMID： 28653572     DOI： 10.2217/imt-2017-0057

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  4 in total

Review 1.  Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.

Authors:  Christopher M Hartshorn; Michelle S Bradbury; Gregory M Lanza; Andre E Nel; Jianghong Rao; Andrew Z Wang; Ulrich B Wiesner; Lily Yang; Piotr Grodzinski
Journal:  ACS Nano       Date:  2017-12-22       Impact factor: 15.881

Review 2.  The paradoxical role of tumor-infiltrating immune cells in lung cancer.

Authors:  Xiaodan Zheng; Yuhai Hu; Chengfang Yao
Journal:  Intractable Rare Dis Res       Date:  2017-11

3.  Prognostic significance of CD4-positive regulatory T cells in tumor draining lymph nodes from patients with bladder cancer.

Authors:  Ali Ariafar; Yasmin Vahidi; Maryam Fakhimi; Ardalan Asadollahpour; Nasrollah Erfani; Zahra Faghih
Journal:  Heliyon       Date:  2020-12-01

Review 4.  Immunologic Milieu of Mature T-Cell and NK-Cell Lymphomas-Implications for Therapy.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.